Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models
スポンサーリンク
概要
- 論文の詳細を見る
- 2009-08-10
著者
-
Ohya Junichi
Research Center, Mitsubishi Chemical Industries Co., Ltd.
-
Fujita Masahide
Experimental Cancer Chemotherapy Research Laboratory Co. Ltd.
-
Ohya Junichi
Research Center Mitsubishi Chemical Industries Co. Ltd.
-
Ohya Junichi
Pharmaceuticals Research Division Mitsubishi Pharma Corporation
-
Fujita Masahide
Association For Anticancer Drug Search
-
SUZUKI Tsuyoshi
Research Division, Mitsubishi Tanabe Pharma Corporation
-
FUJII Akihiro
Research Division, Mitsubishi Tanabe Pharma Corporation
-
NAKAMURA Hideo
Research Division, Mitsubishi Tanabe Pharma Corporation
-
FUJITA Fumiko
Experimental Cancer Chemotherapy Research Laboratories Co.
-
KOIKE Masako
Experimental Cancer Chemotherapy Research Laboratories Co.
-
Suzuki Tsuyoshi
Research Division Mitsubishi Tanabe Pharma Corporation
-
Fujii Akihiro
Research Division Mitsubishi Tanabe Pharma Corporation
-
Nakamura Hideo
Research Division Mitsubishi Tanabe Pharma Corporation
関連論文
- PA63 ACTINOPLANONES, NEW CYTOTOXIC POLYCYCLIC XANTHONES FROM ACTINOPLANES SP.
- Dependence of chemotherapy response on p53 mutation status in a panel of human cancer lines maintained in nude mice
- Antitumor activity of a dual epidermal growth factor receptor and ErbB2 kinase inhibitor MP-412 (AV-412) in mouse xenograft models
- Pharmacological characterization of MP-412 (AV-412), a dual epidermal growth factor receptor and ErbB2 tyrosine kinase inhibitor